SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001674796-22-000009
Filing Date
2022-04-29
Accepted
2022-04-29 11:48:35
Documents
37
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 HST GLOBAL, INC. - FORM 10-Q SEC FILING hstc-20220331.htm   iXBRL 10-Q 179548
2 EXHIBIT 31.1 exhibit31-1.htm EX-31 8032
3 EXHIBIT 31.2 exhibit31-2.htm EX-31 7991
4 EXHIBIT 32.1 exhibit32-1.htm EX-32 3684
5 EXHIBIT 32.2 exhibit32-2.htm EX-32 3801
  Complete submission text file 0001674796-22-000009.txt   1089147

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hstc-20220331_cal.xml EX-101.CAL 16525
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hstc-20220331_def.xml EX-101.DEF 21323
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT hstc-20220331_lab.xml EX-101.LAB 74845
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hstc-20220331_pre.xml EX-101.PRE 65894
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hstc-20220331.xsd EX-101.SCH 32112
31 EXTRACTED XBRL INSTANCE DOCUMENT hstc-20220331_htm.xml XML 61154
Mailing Address 150 RESEARCH DR. HAMPTON VA 23666
Business Address 150 RESEARCH DR. HAMPTON VA 23666 757-766-6100
HST Global, Inc. (Filer) CIK: 0000797564 (see all company filings)

IRS No.: 731215433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15303 | Film No.: 22872063
SIC: 2834 Pharmaceutical Preparations